Lois E. H. Smith

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

Lloyd Paul Aiello, Eric A. Pierce, E D Foley et al. · Proceedings of the National Academy of Sciences · 1995 · 1.3K citations · Full text

Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.

Eric A. Pierce, Robert L. Avery, E D Foley et al. · Proceedings of the National Academy of Sciences · 1995 · 1K citations · Full text

Neovascular Diseases, Ocular Disease, Retinal Neovascularization +16

Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis

Kip M. Connor, Nathan M. Krah, Roberta J. Dennison et al. · Nature Protocols · 2009 · 731 citations · Full text

Ocular Disease, Angiogenesis, Ophthalmology +11

Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis

Kip M. Connor, John Paul SanGiovanni, Chatarina Löfqvist et al. · Nature Medicine · 2007 · 675 citations · Full text

Nutrition, Metabolic Syndrome, Ophthalmology +10

Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor

Lloyd Paul Aiello, Sven-Erik Bursell, Allen C. Clermont et al. · Diabetes · 1997 · 664 citations

Ocular Disease, Retinal Therapies, Vascular Permeability +18